{"nctId":"NCT00002766","briefTitle":"Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma","startDateStruct":{"date":"1996-03"},"conditions":["Leukemia","Lymphoma"],"count":170,"armGroups":[{"label":"ARA-C/High-Dose Mitoxantrone(\"All-2\")","type":"EXPERIMENTAL","interventionNames":["Biological: dactinomycin","Biological: sargramostim","Drug: carmustine","Drug: cyclophosphamide","Drug: cytarabine","Drug: doxorubicin hydrochloride","Drug: etoposide","Drug: mercaptopurine","Drug: methotrexate","Drug: mitoxantrone hydrochloride","Drug: pegaspargase","Drug: prednisone","Drug: vincristine sulfate","Radiation: radiation therapy"]},{"label":"Standard Vincristine/Prednisone (\"L-20\")","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: sargramostim","Drug: carmustine","Drug: cyclophosphamide","Drug: cytarabine","Drug: daunorubicin hydrochloride","Drug: doxorubicin hydrochloride","Drug: methotrexate","Drug: pegaspargase","Drug: prednisone","Drug: vincristine sulfate"]}],"interventions":[{"name":"dactinomycin","otherNames":[]},{"name":"sargramostim","otherNames":[]},{"name":"carmustine","otherNames":[]},{"name":"cyclophosphamide","otherNames":[]},{"name":"cytarabine","otherNames":[]},{"name":"daunorubicin hydrochloride","otherNames":[]},{"name":"doxorubicin hydrochloride","otherNames":[]},{"name":"etoposide","otherNames":[]},{"name":"mercaptopurine","otherNames":[]},{"name":"methotrexate","otherNames":[]},{"name":"mitoxantrone hydrochloride","otherNames":[]},{"name":"pegaspargase","otherNames":[]},{"name":"prednisone","otherNames":[]},{"name":"vincristine sulfate","otherNames":[]},{"name":"radiation therapy","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"DISEASE CHARACTERISTICS:\n\n* Diagnosis of one of the following malignancies:\n\n  * Acute lymphoblastic leukemia (ALL) of B- or T-cell lineage\n  * Philadelphia chromosome-positive ALL eligible\n  * Lymphoblastic lymphoma\n  * Chronic myelogenous leukemia in lymphoid blast crisis\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 18 and over\n\nPerformance status:\n\n* Karnofsky 20-100%\n\nLife expectancy:\n\n* Not specified\n\nHematopoietic:\n\n* Not specified\n\nHepatic:\n\n* Bilirubin no greater than 2.0 mg/dL\n* Glucocorticoids for higher bilirubin allowed prior to entry, at principal investigator's discretion\n\nRenal:\n\n* Creatinine no greater than 2.0 mg/dL\n* Glucocorticoids or renal radiotherapy for higher creatinine allowed prior to entry, at principal investigator's discretion\n\nCardiovascular:\n\n* Left ventricular ejection fraction at least 50%\n\nOther:\n\n* Not pregnant\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* No prior biologic therapy\n\nChemotherapy\n\n* No prior chemotherapy\n\nEndocrine therapy\n\n* No prior endocrine therapy\n\nRadiotherapy\n\n* No prior radiotherapy\n\nSurgery\n\n* No prior surgery","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"120 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Complete Remission (CR)","description":"complete remission (CR) Disappearance of all clinical evidence of leukemia for a minimum of four weeks. The patient should have a neutrophil count \\> 1,000 x 10\\^6/1, a platelet count \\> 100,000 x 10\\^9/1, no circulating blasts, and \\< than or = to blasts on bone marrow differential in a qualitatively normal or hypercellular marrow. Progressive disease or failure: Increasing bone marrow infiltrate or development of organ failure or extramedullary infiltrates due to leukemia.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":39,"n":81},"commonTop":["Hypokalemia","Fatigue","Hypophosphatemia","Pain, other","Abdominal pain/cramping"]}}}